These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11087138)

  • 1. New immunosuppressive agents: a way to get rid of corticosteroids?
    Morelon E; Kreis H
    Transplantation; 2000 Nov; 70(9):1271-2. PubMed ID: 11087138
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids and kidney transplantation.
    Curtis J
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):907-8. PubMed ID: 17699305
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid avoidance or withdrawal after kidney transplantation: a balancing act.
    Sprangers B; Vanrenterghem Y
    Transplantation; 2010 Aug; 90(4):350-2. PubMed ID: 20548264
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
    Behrend M; Lueck R; Pichlmayr R
    Transplant Proc; 1997 Nov; 29(7):2927-9. PubMed ID: 9365617
    [No Abstract]   [Full Text] [Related]  

  • 5. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of steroid-resistant rejection in renal allograft recipients using FK506.
    Mathew A; Talbot D; Minford EJ; Rix D; Starkey G; Forsythe JL; Proud G; Taylor RM
    Transplantation; 1995 Nov; 60(10):1182-4. PubMed ID: 7482730
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
    Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K
    Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 10. Current concepts and perspectives of immunosuppression in organ transplantation.
    Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
    Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation.
    Calconi G; Vianello A;
    Transplant Proc; 2001; 33(1-2):1021-4. PubMed ID: 11267173
    [No Abstract]   [Full Text] [Related]  

  • 12. Rejection after kidney transplantation: new concepts, new therapeutic options.
    van der Woude FJ; Hollander AA
    Transplant Proc; 1998 Aug; 30(5):2419-24. PubMed ID: 9723523
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
    Carl S; Wiesel M
    Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
    [No Abstract]   [Full Text] [Related]  

  • 14. Late steroid withdrawal in kidney transplant recipients.
    Vila A; Ricart MJ; Vilardell JV; Torregrossa F; Cofan JM; Campistol F; Oppenheimer F
    Transplant Proc; 2000 Dec; 32(8):2634-5. PubMed ID: 11134734
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A; Sasvári I; Toronyi E; Borka P; Lázár N; Járay J; Perner F
    Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC; Park SB; Kim HT; Cho WH; Park CH
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract]   [Full Text] [Related]  

  • 17. Allograft rejection and corticosteroids in acute pancreatitis following renal and cardiac transplantation.
    Hagopian EJ; Chabot JA; Oluwole SF; Benvenisty AI; Hardy MA
    Transplant Proc; 1997; 29(1-2):583. PubMed ID: 9123139
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term steroid side effects in renal transplantation need a safe steroid withdrawal: a single-center experience.
    Bertoni E; Zanazzi M; Rosati A; Di Maria L; Moscarelli L; Piperno R; Conti P; Dedola G; Bandini S; Tosi P; Salvadori M
    Transplant Proc; 1998 Jun; 30(4):1303-4. PubMed ID: 9636528
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing the regimen.
    Chapman JR
    Nephrol Dial Transplant; 1995; 10 Suppl 1():51-7. PubMed ID: 7617282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.